HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Cancer Mortality

Cancer Mortality

Cancer mortality persists as a pivotal focus in the realm of cancer research, driving relentless exploration and innovation. Breakthrough treatment methodologies, such as targeted therapies and immunotherapies, hold promise in curbing mortality rates. Advancements in early detection techniques, such as sophisticated imaging technologies and liquid biopsies, are revolutionizing diagnostic accuracy and facilitating timely interventions. Furthermore, an in-depth comprehension of cancer's molecular intricacies is catalyzing the development of personalized treatment regimens, tailored to individual genetic profiles. Effective collaboration among researchers, healthcare practitioners, and policymakers is imperative in translating these advancements into tangible outcomes, ultimately alleviating the global burden of cancer mortality. Despite the challenges ahead, the trajectory of cancer research continues to chart a course towards improved survival rates and elevated quality of life for those impacted by this pervasive disease.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp